0001209191-21-005944.txt : 20210128
0001209191-21-005944.hdr.sgml : 20210128
20210128200011
ACCESSION NUMBER: 0001209191-21-005944
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210121
FILED AS OF DATE: 20210128
DATE AS OF CHANGE: 20210128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dube Eric M
CENTRAL INDEX KEY: 0001763494
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 21567423
MAIL ADDRESS:
STREET 1: 3721 VALLEY CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Travere Therapeutics, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262383102
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 888-969-7879
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Retrophin, Inc.
DATE OF NAME CHANGE: 20130220
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-01-21
2021-01-25
0
0001438533
Travere Therapeutics, Inc.
TVTX
0001763494
Dube Eric M
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Employee stock option (right to buy)
26.88
2021-01-21
4
A
0
212660
0.00
A
2031-01-20
Common Stock
212660
212660
D
This amendment is being filed solely to correct an administrative error in the original Form 4, which reported the number of shares subject to the stock option as 212,600 instead of 212,660.
One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Elizabeth E. Reed, Attorney-in-Fact
2021-01-28